Home » Topics » Infection » HIV/AIDS

HIV/AIDS
RSS

Galen acquires chemotherapy agent from Gilead

Feb. 27, 2012

Scripps Research Institute receives funds to develop new HIV inhibitors

Feb. 27, 2012

Canadian distribution agreement set for tesamorelin

Feb. 22, 2012

Bionor provides update on development of HIV vaccine

Feb. 16, 2012

FDA grants priority review to Truvada sNDA

Feb. 14, 2012

Janssen Pharma seeks Japanese approval of Edurant

Feb. 7, 2012

Novel antiviral agents disclosed by Gilead Sciences

Feb. 3, 2012

Gilead Sciences discloses new agents for HIV infection

Feb. 1, 2012

Phase II trial investigates GS-7340 as part of a new treatment regimen

Jan. 26, 2012

FDA approves new pediatric formulations of Viread

Jan. 19, 2012

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for March 9, 2026.
Cas and effect: Merck’s phase III ripples HIF-2α space
BioWorld
Oddsmakers wasted no time figuring the market chances after Merck & Co. Inc. rolled out data from the phase III Litespark-011 study testing its oral...
News in brief
BioWorld Asia
BioWorld Asia briefs for March 3, 2026
Brain’s hidden tau-clearing pathway uncovered
BioWorld Science
Researchers at INSERM and collaborators have identified hypothalamic tanycytes as mediators of tau clearance and shown that their structural and genetic...
Muscarinic M4 receptor positive allosteric modulators described in Neurosterix patent
BioWorld Science
Neurosterix Pharma Sarl has divulged 3-cyclopropylpyrazole derivatives acting as muscarinic M4 receptor positive allosteric modulators. They are reported to be...